218 related articles for article (PubMed ID: 18420270)
1. Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy.
Meera V; Jijina F; Shrikande M; Madkaikar M; Ghosh K
Leuk Res; 2008 Oct; 32(10):1620-2. PubMed ID: 18420270
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
[TBL] [Abstract][Full Text] [Related]
3. Persistence of molecular remission throughout pregnancy in CML after imatinib.
Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
[No Abstract] [Full Text] [Related]
4. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
[TBL] [Abstract][Full Text] [Related]
6. Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: report of five cases.
Breccia M; Cannella L; Montefusco E; Frustaci A; Pacilli M; Alimena G
Leuk Res; 2008 Mar; 32(3):519-20. PubMed ID: 17804066
[No Abstract] [Full Text] [Related]
7. Imatinib use during pregnancy and breast feeding: a case report and review of the literature.
Ali R; Ozkalemkas F; Kimya Y; Koksal N; Ozkocaman V; Gulten T; Yorulmaz H; Tunali A
Arch Gynecol Obstet; 2009 Aug; 280(2):169-75. PubMed ID: 19083009
[TBL] [Abstract][Full Text] [Related]
8. Fatherhood during imatinib.
Shash E; Bassi S; Cocorocchio E; Colpi GM; Cinieri S; Peccatori FA
Acta Oncol; 2011 Jun; 50(5):734-5. PubMed ID: 21517714
[No Abstract] [Full Text] [Related]
9. Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy.
Ramasamy K; Hayden J; Lim Z; Mufti GJ; Ho AY
Br J Haematol; 2007 May; 137(4):374-5. PubMed ID: 17408403
[No Abstract] [Full Text] [Related]
10. Revised advice on use of imatinib for chronic myeloid leukaemia.
Campbell K
Nurs Times; 2003 Oct 14-20; 99(41):20-1. PubMed ID: 14603651
[TBL] [Abstract][Full Text] [Related]
11. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
Heartin E; Walkinshaw S; Clark RE
Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
[No Abstract] [Full Text] [Related]
12. [Circumventing resistance to imatinib therapy in chronic myeloid leukemia].
Minami Y; Naoe T
Gan To Kagaku Ryoho; 2009 Apr; 36(4):544-7. PubMed ID: 19381024
[TBL] [Abstract][Full Text] [Related]
13. Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis.
Radojkovic M; Ristic S; Pavlovic S; Colovic M
Leuk Res; 2009 Jun; 33(6):e10-2. PubMed ID: 19091403
[TBL] [Abstract][Full Text] [Related]
14. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
Santachiara R; Maffei R; Martinelli S; Arcari A; Piacentini F; Trabacchi E; Alfieri P; Ferrari A; Leonardi G; Luppi G; Longo G; Vallisa D; Marasca R; Torelli G
Haematologica; 2008 Aug; 93(8):1252-5. PubMed ID: 18519520
[TBL] [Abstract][Full Text] [Related]
15. Antituberculosis therapy and imatinib for chronic myeloid leukemia.
Sorà F; De Matteis S; Di Mario A; Maiuro G; Laurenti L; Chiusolo P; Ardito F; Leone G; Sica S
Clin Infect Dis; 2006 Nov; 43(9):1224. PubMed ID: 17029152
[No Abstract] [Full Text] [Related]
16. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
[TBL] [Abstract][Full Text] [Related]
17. Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase.
Stagno F; Vigneri P; Del Fabro V; Stella S; Massimino M; Berretta S; Messina A; Di Raimondo F
Leuk Res; 2009 Jun; 33(6):e17. PubMed ID: 19036439
[No Abstract] [Full Text] [Related]
18. Regression of cutaneous squamous cell carcinoma in a patient with chronic myeloid leukaemia on imatinib mesylate treatment.
Kawakami Y; Nakamura K; Nishibu A; Yanagihori H; Kimura H; Yamamoto T
Acta Derm Venereol; 2008; 88(2):185-6. PubMed ID: 18311459
[No Abstract] [Full Text] [Related]
19. Ocular side effects in chronic myeloid leukemia patients treated with imatinib.
Breccia M; Gentilini F; Cannella L; Latagliata R; Carmosino I; Frustaci A; Alimena G
Leuk Res; 2008 Jul; 32(7):1022-5. PubMed ID: 18061664
[TBL] [Abstract][Full Text] [Related]
20. Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia.
Dvorak P; Hruba M; Subrt I
Leuk Res; 2009 Jun; 33(6):860-1. PubMed ID: 18977531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
